FindTrial
Sign In

The Predictive Value of Triglyceride-Glucose Index for the Incidence of Postoperative Pneumonia in Patients with Non-Small Cell Lung Cancer

The Predictive Value of Triglyceride-Glucose Index for the Incidence of Postoperative Pneumonia in Patients with Non-Small Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116121
Enrollment
Unknown
Registered
2026-01-06
Start date
2025-07-17
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pneumonia in patients with non-small cell lung cancer

Interventions

The postoperative pneumonia group and the non-postoperative pneumonia group:None

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Postoperative pathological diagnosis of non-small cell lung cancer; 2.No prior radiotherapy, chemotherapy, immunotherapy, targeted therapy or other treatments before surgery; 3.Undergoing pneumonectomy;

Exclusion criteria

Exclusion criteria: 1.Patients who underwent stage IV surgery or palliative surgery; 2.Patients diagnosed with pneumonia and/or received antibiotic or hormone therapy within 1 month before surgery; 3.Complicated with autoimmune diseases such as ulcerative colitis and Crohn's disease;

Design outcomes

Primary

MeasureTime frame
Is it pneumonia;—

Countries

China

Contacts

Public ContactRu Pan

Huzhou Center Hospital

40040762@qq.com+86 572 2507099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026